<DOC>
	<DOCNO>NCT01499810</DOCNO>
	<brief_summary>Single-center , single group study efficacy safety transcatheter renal denervation treatment patient essential hypertension uncontrolled despite combined pharmacotherapy include 3 hypotensive drug one diuretic . Bilateral transcatheter renal denervation perform top exist pharmacotherapy . Change blood pressure ( BP ) , leave ventricle ( LV ) mass , carotid artery thickness , renal artery blood flow renal function , assess 6 12 month follow-up .</brief_summary>
	<brief_title>Efficacy Safety Radiofrequency Renal Denervation Drug Resistant Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Age ≥ 18 ≤ 80 year time randomization Informed consent Treatment full dose 3 antihypertensive medication different class , one diuretic . Office Systolic BP ( SBP ) ≥ 160 mmHg Diastolic BP ( DBP ) ≥ 100 mmHg An estimate glomerular filtration rate ( eGFR ) &lt; 30 mL/min/1.73 m2 Ambulatory Blood Pressure Monitoring ( ABPM ) 24 hour average SBP &lt; 135 mmHg DBP &lt; 85 mmHg Symptomatic ( secondary ) hypertension Severe renal artery stenosis renal artery abnormality Individual pregnant , nurse planning pregnant Severe hepatic dysfunction Any clinically important renal , hematological , metabolic , neurological , gastrointestinal , hepatic pulmonary disorder dysfunction prevent study participation ( investigator 's assessment )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Radiofrequency Catheter Ablation</keyword>
	<keyword>Renal Artery</keyword>
	<keyword>Sympathetic Nerve Block</keyword>
</DOC>